Cargando…

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis

INTRODUCTION: The purpose of this study was to perform a systematic review and meta-analysis of exogenous surfactant administration to assess whether this therapy may be useful in adult patients with acute respiratory distress syndrome. METHODS: We performed a computerized literature search from 196...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davidson, Warren J, Dorscheid, Del, Spragg, Roger, Schulzer, Michael, Mak, Edwin, Ayas, Najib T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550886/ https://www.ncbi.nlm.nih.gov/pubmed/16542488 http://dx.doi.org/10.1186/cc4851

Ejemplares similares

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis
por: ZHANG, LI-NA, et al.
Publicado: (2013)

Lung surfactant in subacute pulmonary disease
por: Devendra, Gehan, et al.
Publicado: (2002)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

Acute Lung Injury: Acute Respiratory Distress Syndrome
por: Jamil, Shazia M., et al.
Publicado: (2008)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Exogenous Pulmonary Surfactant as a Vehicle for Antimicrobials: Assessment of Surfactant-Antibacterial Interactions In Vitro
por: Birkun, Alexei
Publicado: (2014)

Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2
por: Baer, Brandon, et al.
Publicado: (2020)

Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

Efficacy of exogenous surfactant in adult patients with acute respiratory failure
por: Tiruvoipati, R, et al.
Publicado: (2006)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
por: Baer, Brandon, et al.
Publicado: (2020)

Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis
por: Zhang, Rongyuan, et al.
Publicado: (2020)

Exogenous pulmonary surfactant prevents the development of intra‐abdominal adhesions in rats
por: Schanaider, Alberto, et al.
Publicado: (2016)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020)

Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012)

In vitro effect of meconium on the physical surface properties and morphology of exogenous pulmonary surfactant.
por: Park, K. H., et al.
Publicado: (1996)

Adsorption of Pulmonary and Exogeneous Surfactants on SARS-CoV-2 Spike Protein
por: Santo, Kolattukudy P., et al.
Publicado: (2023)

Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium
por: Xu, Jie, et al.
Publicado: (2015)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Exogenous Surfactant May Improve Oxygenation but Not Mortality in Adult Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome: A Meta-Analysis of 9 Clinical Trials
por: Meng, Haoyu, et al.
Publicado: (2012)

Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome: A STROBE compliant study
por: Chen, Chen, et al.
Publicado: (2018)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
por: Mao, Zhengrong, et al.
Publicado: (2016)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
por: Lanciotti, Lucia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6am08q9jnml0l5nl0toceenhds